News | August 24, 2022
Jaslok Hospital launches coordination center in Oman
The citizens of Oman will soon have a coordination center that will provide end to end services for healthcare facilities of Jaslok.
The citizens of Oman will soon have a coordination center that will provide end to end services for healthcare facilities of Jaslok.
The approved product has an estimated market size of around US $62 million for the twelve months ending June 2022 according to IQVIA
75 inter-disciplinary, multi-institutional grants would be supported for high-risk, ambitious research ideas, milestones-driven collaborative research in all domain areas of the biotech sector
This rapid analytical technique provides additional information about the polymorph and solid-state properties of active pharmaceutical ingredients (APIs)
The company is relieving all its staff who were directly engaged by our US subsidiary in its plant in connection with the manufacturing process in a phased manner
Ascletis is China's first biotech company which has obtained IND approvals of an oral RdRp inhibitor from both China NMPA and the U.S. FDA
DEP® ADCs exploit the unique potential of Starpharma's DEP® technology to provide enhanced characteristics to ADCs i
OrderPoint was designed as an advanced DTR solution from its first release in 2016.
Genentech will be granted an exclusive license to develop and commercialize the degrader worldwide, and will be fully responsible for the development and commercialization costs.
The study concluded that elevated levels of two proteins help predict how a person will recover from a traumatic brain injury (TBI), providing important information to determine appropriate care
Subscribe To Our Newsletter & Stay Updated
